Concepts in epidemiology: the cohort effect
Author: Terence M Mills
Published online: 19 March 2012
Incidence rates of cancer vary over time;1 this is called a “period effect”. Incidence rates of cancer also tend to increase with age;1 this is called an “age effect”. Another time variable that is associated with the incidence of cancer is year of birth of the patient — the “cohort effect”. Many authors have used real data to emphasise the importance of cohort effects for assessing trends in incidence.2,3 Here, I present a simple, hypothetical example to illustrate the cohort effect.
Consider the data shown in the Box. In this hypothetical population, the age groups are 0–29, 30–59 and 60–89 years and everyone dies on their 90th birthday. The Box contains data for three years (1940, 1970 and 2000). For each year and age group, n denotes the size of the population, P denotes the probability of being diagnosed with cancer in the year, and EI denotes the expected incidence (the expected number of new cases of cancer), which is calculated with the formula:
In 1940, in the 0–29-year age group, there were 600 people, the probability of being diagnosed with cancer was 0.01, and the EI was thus 600 × 0.01 = 6. In the whole population, 41 of 1000 people are expected to be diagnosed with cancer.
In this scenario, a wonder drug that prevents cancer was discovered in 1941. However, it must be administered in utero, so only people born since 1941 can benefit.
In 1970, assume there were 100 people aged 0–29 years. In this group, the probability of being diagnosed with cancer was 0, because they were born since 1941, and the EI was 0. The 600 people, who were aged 0–29 years in 1940, were aged 30–59 years in 1970; the probability of being diagnosed with cancer in that age group was 0.05, as in 1940; so the EI was 30. In the whole population, 90 of 1000 people are expected to be diagnosed with cancer in 1970.
In 2000, only those aged 60–89 years were born before 1941. Overall, 120 of 1000 people are expected to be diagnosed with cancer.
Thus, in 1940 there would be 41 new cases in a population of 1000, in 1970 there would be 90 new cases in a population of 1000, and in 2000 there would be 120 new cases in a population of 1000. This trend suggests that things will be worse in 2030.
In fact, the disease will disappear in 2030.
A hypothetical population that illustrates the cohort effect
Competing interests
References
- Australian Institute of Health and Welfare. Cancer in Australia 2010: an overview. Canberra: AIHW, 2010. (AIHW Cat. No. 56; Cancer Series No. 60.) 0_CHDJEJHD
- Gardner MJ, Osmond C. Interpretation of disease time trends: is cancer on the increase? A simple cohort technique and its relationship to more advanced models. J Epidemiol Community Health 1983; 37: 274-278. 0_i1143011
- Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991; 12: 425-457. 0_i1143013
Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study
Evangeline Samuel, Eldho Paul, Mike Lloyd, Sanuki Tissera, Craig Underhill, Sagun Parakh, Phillip Parente, Inger Olesen, Javier Torres, Katharine See, Gavin M. Wright, David Langton, Thomas John, Matthew Conron, James Bartlett, Nicola Atkin, Nikolajs Zeps, Susan V. Harden, Wasek Faisal, John R. Zalcberg, Rob G. Stirling
Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009–2024) to Guide Treatment Planning
Savio G. Barreto, Christos S. Karapetis, Shahid Ullah, Matthew Burge, Susan Caird, Angus Campbell, Azim Jalali, Ross Jennens, Muhammad A. Khattak, Belinda Lee, Stephanie H. Lim, Shehara Mendis, Louise Nott, Timothy J. Price, Jeremy D. Shapiro, Jeanne Tie, Javier Torres, Colin Williams, Rachel Wong, Vanessa Wong, Peter Gibbs
Australian Pathways for Specialist Pain Management and Early Palliative Care for People With Pancreatic Cancer: Developed Using a Community Consensus Approach
Jennifer Philip, Melanie R. Lovell, Kylee Bellingham, Gail Garvey, Gregory B. Crawford, Nicole M. Rankin, Kara Burns, Isabel Young, Vivienne Milch, Dorothy Keefe, Katrina Anderson, James Lawson, Meinir Krishnasamy
Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia
Nicole M. Rankin, Rebecca Zosel, Lisa J. Whop, Raglan Maddox, Annette McWilliams, Miranda Siemienowicz, Jon Emery, Maria A. R. Lantin, Georgia Bartlett, Mikayla Wolfe, Abbey Diaz, Katrina Anderson, Lillian Liu, Cindy Toms, Sarah McDermott, Peter Bligh, Jeremy Chalke, Stephen Melsom, Claire E. Nightingale, Alison Brown, Sam Pope, Julia Brotherton, Anne Fidler, Michel Itel, Mark Brooke, Diane M. Pascoe, Fraser Brims, Tracy L. Leong, Emily Stone, Dorothy Keefe, Vivienne Milch
Beyond Mammography: Sovereignty and Relational Breast Care With Aboriginal and Torres Strait Islander Women
Devaleena Das, Jessica Gildersleeve, Amy Thomson, Aunty Gracelyn Smallwood, Lorelle Holland
Striving for Racial Equity in Oral Cancer Research: A Case Study
Sneha Sethi, Simon Naylor, Catherine Leane (Dharug/Gabrigal), Gail Garvey (Kamilaroi), Joanne Hedges (Yamatji), Lisa M. Jamieson, Nicolas Reid (Dharug/Gabrigal)